Get the Stockscreener App
79.30
0.92%
0.72
Pre-market:
78.62
-0.68
-0.86%
Prestige Consumer Healthcare Inc stock is traded at $79.30, with a volume of 261.97K.
It is up +0.92% in the last 24 hours and up +0.74% over the past month.
See More
Previous Close:
$78.58
Open:
$79.13
24h Volume:
261.97K
Relative Volume:
1.01
Market Cap:
$3.68B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
19.29
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
+4.65%
1M Performance:
+0.74%
6M Performance:
+11.31%
1Y Performance:
+33.21%
1-Day Range:
$79.13
$80.00
1-Week Range:
$75.95
$80.00
52-Week Range:
$59.38
$86.36
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
79.30 | 3.68B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Assenagon Asset Management S.A. Grows Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
US Q4 Consumer Health Earnings Preview: Executive, ‘Playbook’ And ‘Fundamental’ Changes - News & Insights
The 6.2% return this week takes Prestige Consumer Healthcare's (NYSE:PBH) shareholders five-year gains to 92% - Yahoo Finance
Zacks Research Has Bearish Estimate for PBH Q2 Earnings - Defense World
StockNews.com Downgrades Prestige Consumer Healthcare (NYSE:PBH) to Hold - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Rating Lowered to Hold at StockNews.com - MarketBeat
HRG’s five notable products from December 2024 - Drug Store News
Zacks Research Brokers Reduce Earnings Estimates for PBH - MarketBeat
Zacks Research Has Bullish Estimate for PBH FY2025 Earnings - Defense World
Zacks Research Issues Optimistic Forecast for PBH Earnings - MarketBeat
Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now - Simply Wall St
Canaccord maintains Buy on Prestige Brands stock By Investing.com - Investing.com Canada
PBH or BSX: Which Is the Better Value Stock Right Now? - Yahoo Finance
GAMMA Investing LLC Increases Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
JPMorgan Chase & Co. Acquires 8,533 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Bought by JPMorgan Chase & Co. - MarketBeat
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation - The Manila Times
Prestige Consumer Healthcare Announces Fiscal 2025 Third - GlobeNewswire
Prestige Consumer Healthcare Sets Q3 Earnings Date, Plans ICR Conference Appearance - StockTitan
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to Buy at StockNews.com - Defense World
**Prestige Consumer Healthcare Appoints Christine Sacco as Chief Operating Officer** - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to "Buy" at StockNews.com - MarketBeat
Prestige Consumer Healthcare Enters Oversold Territory (PBH) - Nasdaq
(PBH) Technical Data - Stock Traders Daily
Prestige Consumer Healthcare Inc. Expands CFO Christine - GlobeNewswire
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco?S Role to Include Chief Operating Officer Responsibilities - Marketscreener.com
Prestige Consumer Healthcare Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities - citybiz
Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco's Role to Include Chief Operating Officer Responsibilities - The Manila Times
Cerence AI to Present at 27th Annual Needham Growth Conference - The Manila Times
Prestige Consumer Healthcare Expands CFO Role to COO in Strategic Leadership Move - StockTitan
Everence Capital Management Inc. Lowers Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Brokerages Set Prestige Consumer Healthcare Inc. (NYSE:PBH) Target Price at $85.25 - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $85.25 Average Price Target from Brokerages - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Downgraded to Hold Rating by StockNews.com - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Rating Lowered to "Hold" at StockNews.com - MarketBeat
PBH vs. BSX: Which Stock Is the Better Value Option? - Yahoo Finance
Should Prestige Consumer Stock Stay in Your Portfolio Right Now? - MSN
Principal Financial Group Inc. Cuts Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
(PBH) Proactive Strategies - Stock Traders Daily
Investing in Prestige Consumer Healthcare (NYSE:PBH) five years ago would have delivered you a 94% gain - Simply Wall St
MML Investors Services LLC Has $312,000 Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Stifel Financial Corp Purchases 2,322 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded at Raymond James - Defense World
Geode Capital Management LLC Purchases 50,961 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
StockNews.com Upgrades Prestige Consumer Healthcare (NYSE:PBH) to “Buy” - Defense World
Barclays PLC Buys 71,730 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by StockNews.com - MarketBeat
Jane Street Group LLC Has $4.71 Million Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Wellington Management Group LLP Makes New Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Trend Tracker for (PBH) - Stock Traders Daily
Feminine Hygiene Products Market Size Projected to Reach 47.98 Billion by 2032SNS Insider - India Shorts
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):